Legal Representation
Attorney
SCOTT D WOLDOW
USPTO Deadlines
Application History
32 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 30, 2013 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jul 27, 2009 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jul 27, 2009 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Dec 24, 2008 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 24, 2008 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Dec 24, 2008 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Jun 3, 2008 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 3, 2008 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Jun 3, 2008 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Jan 17, 2008 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Dec 20, 2007 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 20, 2007 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Aug 31, 2007 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jun 12, 2007 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 12, 2007 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Dec 15, 2006 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 15, 2006 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Dec 15, 2006 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jun 27, 2006 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jun 14, 2006 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | Loading... |
| Apr 4, 2006 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 15, 2006 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Feb 16, 2006 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Feb 3, 2006 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jan 30, 2006 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jan 30, 2006 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 18, 2006 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jan 18, 2006 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 29, 2005 | CPRA | F | PRIORITY ACTION MAILED | Loading... |
| Jul 28, 2005 | CPRA | R | PRIORITY ACTION WRITTEN | Loading... |
| Jul 27, 2005 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 11, 2005 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of disorders and diseases of the respiratory system, gastrointestinal system, endocrine system, cardiovascular system, nervous system, musculoskeletal system, urinary system, integumentary system and reproductive system, pharmaceutical preparations for the treatment of blood diseases and disorders; dermatologic pharmaceutical preparations; antimycotic pharmaceutical preparations; hormone therapy preparations; medical diagnostic reagents; pharmaceutical preparations for the treatment of colds, coughs and influenza; pharmaceutical preparations for ophthalmic use; pharmaceutical preparations for treating dandruff; laxatives; analgesics, antipyretics, antispasmodics; oral contraceptives, antiseptics, pharmaceutical preparations for the treatment of hypotension, pharmaceutical preparations for the treatment of hypertension, pharmaceutical preparations for the treatment of obesity; antiallergic pharmaceutical preparations; pharmaceutical preparations for the treatment of gout; anti-inflammatory pharmaceuticals; antibiotics, antineoplastics, pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for asthma; pharmaceutical preparations for mouth and gum disease; pharmaceutical preparations for the treatment for vertigo, pharmaceutical preparations for the treatment of nausea; pharmaceutical preparations for the treatment of migraines; pharmaceutical preparations for the treatment of Parkinson's disease; pharmaceutical preparations for treating AIDS and related symptoms; vitamin preparations; mineral additive dietary supplements; vaccines; X-ray contrast agents
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005